Boston Scientific stock rallied Wednesday despite cutting its 2026 outlook. An analyst says this could offer a reset for shares.
Boston Scientific (BSX) came out with quarterly earnings of $0.8 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.75 per share a year ago.
Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a first-quarter earnings and revenue beat, while its shares were little changed after earlier volatility.
Boston Scientific said its first-quarter net income roughly doubled as demand continued to grow worldwide for its stents, catheters and other cardiology devices.
CPC Advisors LLC lowered its holdings in Boston Scientific Corporation (NYSE: BSX) by 54.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,851 shares of the medical equipment provider's stock after selling 27,747 shares during the
Boston Scientific Corporation (NYSE:BSX) will release earnings for its first quarter before the opening bell on Wednesday, April 22.
Boston Scientific (NYSE: BSX) trades around $61, with analyst price targets ranging from $69 (conservative) to $124 (optimistic), implying substantial upside.
Boston Scientific heads into Q1 earnings with strong Cardiovascular momentum and steady MedSurg growth, as estimates point to solid revenue and earnings gains.
Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2026.
Boston Scientific (BSX) closed the most recent trading day at $64.61, moving +1.24% from the previous trading session.
Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.